Trial Profile
18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary) ; Florbetapir F 18
- Indications Dementia
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 08 Jan 2019 Status changed from recruiting to completed.
- 08 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 08 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.